bf/NASDAQ:BCRX_icon.jpeg

COM:BIOCRYST

BioCryst Pharmaceuticals, Inc.

  • Stock

Last Close

7.55

26/07 20:00

Market Cap

1.34B

Beta: -

Volume Today

2.28M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
17.33M
-
13.61M
21.48%
48.26M
254.62%
26.35M
45.39%
25.19M
4.43%
20.65M
18.00%
48.84M
136.45%
17.81M
63.53%
157.17M
782.38%
270.83M
72.31%
331.41M
22.37%
cost of revenue
98K
-
122K
24.49%
1.90M
1,454.10%
2.70M
42.35%
1.70M
36.94%
471K
72.33%
4.10M
770.70%
1.68M
59.13%
7.26M
333.41%
6.59M
9.22%
6.32M
4.22%
gross profit
17.23M
-
13.49M
21.74%
46.36M
243.77%
23.65M
48.98%
23.48M
0.72%
20.18M
14.06%
44.73M
121.65%
16.14M
63.93%
149.91M
829.02%
264.23M
76.27%
325.10M
23.03%
selling and marketing expenses
6.57M
-
5.71M
13.13%
14.89M
161.02%
general and administrative expenses
5.22M
-
7.46M
42.93%
13.05M
74.87%
11.25M
13.75%
13.93M
23.82%
29.51M
111.83%
61.36M
-
113.11M
84.34%
144.48M
27.73%
selling general and administrative expenses
5.22M
-
7.46M
42.93%
13.05M
74.87%
11.25M
13.75%
13.93M
23.82%
29.51M
111.83%
37.12M
25.77%
67.93M
82.99%
118.82M
74.91%
159.37M
34.13%
213.89M
34.21%
research and development expenses
42.73M
-
51.80M
21.22%
72.76M
40.47%
61.01M
16.15%
66.96M
9.76%
84.89M
26.77%
107.07M
26.13%
122.96M
14.85%
208.81M
69.81%
253.30M
21.31%
214.91M
15.15%
other expenses
28.06M
-
41.37M
47.43%
33.71M
18.52%
47.01M
39.46%
54.38M
15.68%
70.81M
30.21%
82.44M
16.43%
111.96M
35.80%
202.92M
81.25%
253.27M
24.81%
180K
99.93%
cost and expenses
48.05M
-
59.38M
23.58%
87.70M
47.70%
74.96M
14.53%
82.60M
10.19%
114.87M
39.08%
148.29M
29.09%
192.57M
29.86%
334.89M
73.91%
419.26M
25.19%
435.12M
3.78%
operating expenses
47.95M
-
59.26M
23.58%
85.81M
44.80%
72.26M
15.78%
80.89M
11.95%
114.40M
41.42%
144.19M
26.04%
190.89M
32.39%
327.63M
71.63%
412.67M
25.96%
428.81M
3.91%
interest expense
4.78M
-
5.00M
4.60%
5.20M
4.04%
6.49M
24.75%
8.56M
32.03%
9.18M
7.13%
11.89M
29.60%
14.50M
21.94%
59.29M
308.90%
99.09M
67.12%
108.24M
9.23%
ebitda
-30.62M
-
-45.68M
49.16%
-38.91M
14.82%
-47.81M
22.89%
-56.40M
17.95%
-91.97M
63.08%
-97.52M
6.04%
-165.34M
69.54%
-177.66M
7.45%
-143.31M
19.33%
-102.05M
28.79%
operating income
-30.72M
-
-45.77M
49.01%
-39.44M
13.82%
-48.61M
23.23%
-57.41M
18.11%
-94.22M
64.11%
-99.45M
5.56%
-174.76M
75.71%
-177.72M
1.70%
-148.44M
16.48%
-103.71M
30.13%
depreciation and amortization
304K
-
177K
41.78%
180K
1.69%
483K
168.33%
704K
45.76%
770K
9.38%
1.93M
151.04%
9.42M
387.33%
62K
99.34%
5.13M
8,169.35%
1.66M
67.72%
total other income expenses net
5.29M
-
5.49M
3.65%
1.09M
80.13%
-843K
177.34%
-821K
2.61%
-108K
86.85%
-9.44M
8,642.59%
-8.06M
14.67%
-4.09M
49.25%
-95.95M
2,246.52%
-122.52M
27.69%
income before tax
-30.11M
-
-45.19M
50.09%
-43.02M
4.80%
-55.14M
28.19%
-65.78M
19.29%
-101.25M
53.92%
-108.90M
7.55%
-182.81M
67.88%
-181.81M
0.55%
-244.38M
34.42%
-226.23M
7.43%
income tax expense
4.47M
-
4.82M
7.76%
5.02M
4.13%
6.00M
19.60%
7.86M
30.93%
2.14M
72.73%
11.17M
420.90%
13.75M
23.15%
2.25M
83.62%
2.73M
21.30%
310K
88.66%
net income
-30.11M
-
-45.19M
50.09%
-43.02M
4.80%
-55.14M
28.19%
-65.78M
19.29%
-101.25M
53.92%
-120.06M
18.58%
-196.57M
63.72%
-184.06M
6.36%
-247.12M
34.26%
-226.54M
8.33%
weighted average shs out
55.22M
-
66.77M
20.93%
72.90M
9.18%
73.70M
1.09%
84.45M
14.59%
103.19M
22.18%
115.60M
12.03%
167.27M
44.69%
179.12M
7.08%
185.91M
3.79%
192.20M
3.38%
weighted average shs out dil
55.22M
-
66.77M
20.93%
72.90M
9.18%
73.70M
1.09%
84.45M
14.59%
103.19M
22.18%
115.60M
12.03%
167.27M
44.69%
179.12M
7.08%
185.91M
3.79%
192.20M
3.38%
eps
-0.55
-
-0.68
23.64%
-0.59
13.24%
-0.75
27.12%
-0.78
4.00%
-0.98
25.64%
-1.04
6.12%
-1.18
13.46%
-1.03
12.71%
-1.33
29.13%
-1.18
11.28%
epsdiluted
-0.55
-
-0.68
23.64%
-0.59
13.24%
-0.75
27.12%
-0.78
4.00%
-0.98
25.64%
-1.04
6.12%
-1.18
13.46%
-1.03
12.71%
-1.33
29.13%
-1.18
11.28%

All numbers in (except ratios and percentages)